Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy

por Shin, Chang-Ae, Cho, Hyun-Woo, Shin, A-Ri, Sohn, Hyun-Jung, Cho, Hyun-Il, Kim, Tai-Gyu
Publicado 2016

Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial

por Kim, Hee-Je, Sohn, Hyun-Jung, Hong, Jung-A, Lee, Hyun-Joo, Sohn, Dae-Hee, Shin, Chang-Ae, Cho, Hyun-Il, Min, Woo-Sung, Kim, Tai-Gyu
Publicado 2018